BTCEs work by harnessing the patient own immune system to induce T cell mediated cytotoxicity against malignant cells through the production of inflammatory cytokines such as TNF-α and IFN-γ and the release of perforin and granzyme which in turn led to the killing of cancer cells. The gene discussed is IFNG; the disease is cancer.